How to reduce mortality in ST-elevation myocardial infarction patients treated with primary percutaneous coronary interventions: cut the bleeding

References

• Eagle KA, Nallamothu BK, Metha RH, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 2008;29:609-6
   PubMed Web of Science ®Google Scholar
• Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-30
   PubMed Web of Science ®Google Scholar
• Suh JW, Mehran R, Claessen BE, et al. Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction. The HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) Trial. J Am Coll Cardiol 2011;58:1750-6
   PubMed Web of Science ®Google Scholar
• Arzamendi D, Ly HQ, Tanguay JF, et al. Effect on bleeding, time to revascularization, and one-year clinical outcomes of the radial approach during primary percutaneous coronary intervention in patients with st-segment elevation myocardial infarction. Am J Cardiol 2010;106:148-54
   PubMed Web of Science ®Google Scholar
• Jolly SS, Yusuf S, Cairns J, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 2011;377:1409-20
   PubMed Web of Science ®Google Scholar
• Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome. The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) Study. J Am Coll Cardiol 2012;60:2481-9
   PubMed Web of Science ®Google Scholar
• Jang JS, Jin HY, Seo JS, et al. The transradial versus the transfemoral approach for primary percutaneous intervention in patients with acute myocardial infarction: a systematic review and meta-analysis. Eurointervention 2012;8:501-10
   PubMed Web of Science ®Google Scholar
• Généreux P, Mehran R, Palmerini T, et al. Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial. EuroIntervention 2011;7:905-16
   PubMed Web of Science ®Google Scholar
• Stone GW, Witzenbichler B, Guagliumi G, et al.; for the HORIZONS-AMI trial investigators. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet 2011;377:2193-204
   PubMed Web of Science ®Google Scholar
• Parodi G, Antoniucci D, Nikolsky E, et al. Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction. J Am Coll Cardiol Cardiovasc Interv 2010;3:796-802
   PubMed Web of Science ®Google Scholar
• Pinto DS, Ogbonnaya A, Sherman SA, et al. Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: Results from an observational database. Circ Cardiovasc Qual Outcomes 2012; 5:52-61
   PubMed Web of Science ®Google Scholar
• Wohrle J, Merkle N, Kunze M, et al. Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the HORIZONS-AMI CMRI substudy. Cathet Cardiovasc Interv 2012;79:1083-9
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774-882
   PubMed Web of Science ®Google Scholar
• Yusuf S, Mehta SR, Chrolavicius S, et al. Fifth organization to assess strategies in acute ischemic syndromes investigators. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006;354:1464-76
   PubMed Web of Science ®Google Scholar
• Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. J Am Med Assoc 2004;292:1555-62
   PubMed Web of Science ®Google Scholar
• Hermanides RS, Ottervanger JP, Dambrink JHE, et al. Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction. EuroIntervention 2010;6:106-11
   PubMed Web of Science ®Google Scholar
• Kadakia MB, Desai NR, Alexander KP, et al. Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry – GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry – Get With the Guidelines). J Am Coll Cardiol Cardiovasc Interv 2010;3:1166-77
   PubMed Web of Science ®Google Scholar
• Koutouzis M, Lagerqvist B, James S, et al. Unfractionated heparin administration in patients treated with bivalirudin during primary percutaneous coronary intervention is associated lower mortality and target lesion thrombosis: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Heart 2011;97:1484-8
   PubMed Web of Science ®Google Scholar
• Xiao Z, Theroux P. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation 1998;97:251-6
   PubMed Web of Science ®Google Scholar
• Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15
   PubMed Web of Science ®Google Scholar
• Gersh BJ, Anderson JL. Thrombolysis and myocardial salvage results of clinical trials and the animal paradigm: paradoxic or predictable? Circulation 1993;88:296-306
   PubMed Web of Science ®Google Scholar
• Verheugt FWA, Steinhubl SR, Hamon M, et al. Incidence, prognostic impact, influence of antithrombotic therapy on access and non access site bleeding in percutaneous coronary intervention. J Am Coll Cardiol Cardiovasc Interv 2011;4:191-7
   PubMed Web of Science ®Google Scholar
• MacHaalany J, Abdelaal E, Bataille Y, et al. Benefit of bivalirudin versus heparin after transradial and transfemoral percutaneous coronary intervention. Am J Cardiol 2012;110:1742-8
   PubMed Web of Science ®Google Scholar
• EArly disharge after transradial Stenting of coronarY artery in high-risk patients of bleeding: Bivalirudin To reduce Bleeding. EASY-B2B trial. Available at: www.clinicaltrials.gov [Last accessed 8 January 2013]
   Google Scholar